NCT06942416 2025-04-24Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical CancerShandong Cancer Hospital and InstitutePhase 2 Recruiting36 enrolled